Magle Chemoswed Holding AB (publ): BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator
Magle Group has partnered with Heidelberg University Hospital in Germany to launch a study evaluating the effectiveness of SmartPAN in pancreatic surgery. This post-market study aims to further explore SmartPAN's ability to detect and prevent pancreatic fluid leakage following surgical procedures.
Read the article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/